Side effects of rovastatin
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Side Effects of Rosuvastatin: A Comprehensive Overview
Common Side Effects of Rosuvastatin
Myopathy and Muscle-Related Issues
Rosuvastatin, like other statins, is associated with muscle-related side effects, including myopathy and rhabdomyolysis. These conditions are characterized by muscle pain, weakness, and in severe cases, muscle breakdown leading to kidney damage . Although these side effects are relatively rare, they are significant enough to warrant caution, especially at higher doses or when combined with other medications that increase rosuvastatin levels in the blood.
Liver Enzyme Elevations
Asymptomatic elevations in liver enzymes are another side effect observed with rosuvastatin use. These elevations are generally mild and occur at a similar rate to other statins. Regular monitoring of liver function is recommended to detect any potential liver damage early.
Renal Impairment
Higher doses of rosuvastatin have been linked to renal impairment and proteinuria, which is the presence of excess proteins in the urine. This condition is thought to result from the inhibition of low-molecular-weight protein reabsorption by the renal tubules. However, a large retrospective analysis found no significant increase in the risk of renal failure or impairment in patients without pre-existing advanced renal disease.
Gastrointestinal and Central Nervous System Effects
Rosuvastatin can also cause gastrointestinal issues such as constipation, nausea, and abdominal pain, as well as central nervous system effects like dizziness and pruritus (itchiness) . These side effects are generally mild and transient but can be bothersome for some patients.
Diabetes Mellitus
There is evidence suggesting that rosuvastatin may slightly increase the incidence of diabetes mellitus and elevate glycated hemoglobin levels, particularly in older patients with multiple risk factors and low-grade inflammation. This potential risk should be considered, especially in patients already at risk for diabetes.
Drug-Drug Interactions
Increased Risk with Certain Medications
Rosuvastatin's pharmacokinetic profile means it has fewer interactions with the cytochrome P450 system compared to other statins. However, it can still interact with drugs that inhibit its hepatic uptake, such as cyclosporine, gemfibrozil, and certain antiretroviral agents, increasing the risk of toxicity. Clinicians should exercise caution when prescribing rosuvastatin alongside these medications.
Safe Combinations
Conversely, rosuvastatin appears to be safe when used in combination with fenofibrate, ezetimibe, omega-3 fatty acids, antifungal azoles, rifampin, or clopidogrel, as no significant pharmacokinetic or pharmacodynamic interactions have been reported with these drugs.
Conclusion
Rosuvastatin is a potent statin with a relatively favorable safety profile. While it shares common side effects with other statins, such as myopathy, liver enzyme elevations, and potential renal impairment, these are generally rare and manageable. The drug's interactions with other medications are also relatively limited, making it a versatile option for managing dyslipidemia. However, the slight increase in diabetes risk and the need for caution with certain drug combinations highlight the importance of individualized patient assessment and monitoring.
Sources and full results
Most relevant research papers on this topic